Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > This was posted Jan.21, 2021 sort of explains why Guy is

<< Previous

Bullboard Posts

Next >>

Comment by naturalstuff555on Feb 25, 2022 1:10pm

170 Views

Post# 34462161

RE:This was posted Jan.21, 2021 sort of explains why Guy is

Thank you for these informacions Sam. I've been here since 2017 as well..I dont think theyll survive.very bad liers these guyss. The recent NR appeared to me as..DIVERSION to forget their unreachable pipeline w all the exceeded deadlines ! But do you think there's opening for class action looking at theses money transfers to other companies...they own !!! How can we start this eventually here in Quebec
Thanks

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide